AIDS Home > Egrifta and Breastfeeding
In animal studies on Egrifta (tesamorelin) and breastfeeding, the offspring suffered serious side effects. As a result, the manufacturer recommends that women avoid breastfeeding when taking this drug. This aligns with the CDC recommendation that U.S. women with HIV avoid breastfeeding in order to prevent possibly transmitting the virus to their infants.
Can Breastfeeding Women Take Egrifta?At this time, it is unknown if Egrifta™ (tesamorelin acetate) passes through breast milk in humans. Animal studies showed that using Egrifta while breastfeeding caused serious side effects in the offspring. The manufacturer recommends that women who take this medication not breastfeed.
More importantly, the Centers for Disease Control and Prevention (CDC) recommends that mothers in the United States who are infected with human immunodeficiency virus (HIV) not breastfeed. The HIV virus can pass through breast milk, possibly leading to transmission to the infant.